The Critical American Biotech Stock Fast-Tracked by the FDA

Because of the role they’re playing in helping solve Covid-19, this U.S. biotech firm was recently fast-tracked by the FDA… and given a rare “Emergency Use Authorization”…

It provides the testing equipment researchers need to evaluate their different treatments for the coronavirus. This equipment is used by over 10,000 research labs worldwide and that number is growing at a rapid pace.

But not only that – this company also has a brand-new model slated to come out in the fourth quarter!

It’s like whenever Apple releases a new iPhone. Share prices spike.

Same thing here – Every time this company introduced new models in the past… It has led to a massive influx in revenue and share price.

  • Back in 2007, when the company introduced its first model, shares rose 238%…
  • In 2009, it happened again. Shares tripled…
  • In 2012, same story again. Shares surged 365%…
  • And in 2017, shares rose another 189%.

So, it’s critical people take a position… Before the new model comes out.

Sign up below for the full details on the company and their important technology, including how to get the ticker symbol before the next big release.

Simply enter your email address below to get a free copy of our report and you’ll also get ongoing updates from Breakthrough Investor.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy


By submitting your email address, you give Breakthrough Investor permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works